Patent details

Basic Information

Publication number:

EP3616722

PCT Application Number:

JP2018017158

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP187913033

PCT Publication Number:

WO2018199281

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION

French Title of Invention:

COMPOSITION PHARMACEUTIQUE

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNG

SPC Number:

Dates

Filing date:

27/04/2018

Grant date:

25/10/2023

EP Publication Date:

04/03/2020

PCT Publication Date:

01/11/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/10/2023

EP B1 Publication Date:

25/10/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/04/2024

Expiration date:

27/04/2038

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/10/2023

 

 

Name:

Astellas Pharma Inc.

Address:

5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, Japan (JP)

Inventor

1

Name:

SHIMADA Ken

Address:

Japan (JP)

2

Name:

UMEMOTO Yoshiaki

Address:

Japan (JP)

3

Name:

NAMIKI Sachie

Address:

Japan (JP)

4

Name:

YOSHIDA Takatsune

Address:

Japan (JP)

5

Name:

KOJIMA Hiroyuki

Address:

Japan (JP)

6

Name:

TAKAGI Akira

Address:

Japan (JP)

Priority

Priority Number:

2017090299

Priority Date:

28/04/2017

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 45/00; A61K 31/4422; A61K 47/32; A61K 9/16; A61K 31/436;

Publication

European Patent Bulletin

Issue number:

202343

Publication date:

25/10/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages